Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
Public ClinicalTrials.gov record NCT01421134. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Lurasidone HCl is a compound that is a candidate for the treatment of major depressive with mixed features.This clinical study is designed to test how well Lurasidone works to treat major depressive disorder with mixed features.
Study identification
- NCT ID
- NCT01421134
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 211 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2011
- Primary completion
- Sep 30, 2014
- Completion
- Sep 30, 2014
- Last update posted
- Jul 14, 2016
2011 – 2014
United States locations
- U.S. sites
- 19
- U.S. states
- 10
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Birmingham Psychiatry Pharmaceutical Studies, Inc. | Birmingham | Alabama | 35226 | — |
| Synergy Clinical Research Center | Escondido | California | 92025 | — |
| Collaborative Neuroscience Network Inc. | Garden Grove | California | 92845 | — |
| Stanford -VA Palo Alto Health Care System | Palo Alto | California | 94304 | — |
| Clinical Innovations Inc. | Riverside | California | 92506 | — |
| Artemis Institute for Clinical Research | San Diego | California | 92123 | — |
| Florida Clinical Research Center, LLC | Sarasota | Florida | 34201 | — |
| Massachusetts General Hospital - Center for Anxiety and Traumatic Stress Disorders | Boston | Massachusetts | 02114 | — |
| St. Charles Psychiatric Associates/Midwest Research Group | Saint Charles | Missouri | 63301 | — |
| Social Psychiatric Research Inst. (SPRI) Clinical Trials | Brooklyn | New York | 11235 | — |
| Village Clinical Research Inc. | New York | New York | 10003 | — |
| Finger Lakes Clinical Research | Rochester | New York | 14618 | — |
| Behavioral Medical Research of Staten Island | Staten Island | New York | 10305 | — |
| Psychiatry and Behavioral Sciences, Duke | Durham | North Carolina | 27705 | — |
| Midwest Clinical Research Center | Dayton | Ohio | 45417 | — |
| CRI Worldwide - Kirkbride | Philadelphia | Pennsylvania | 19139 | — |
| FutureSearch Trials of Dallas, LP | Dallas | Texas | 75231 | — |
| Dept. of Psychiatry, UT Southwestern Medical Center | Dallas | Texas | 75390-8849 | — |
| Grayline Clinical Drug Trials | Wichita Falls | Texas | 76309 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01421134, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 14, 2016 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01421134 live on ClinicalTrials.gov.